AMEFX
Price
$25.89
Change
-$0.24 (-0.92%)
Updated
Nov 12 closing price
FASGX
Price
$29.09
Change
-$0.22 (-0.75%)
Updated
Nov 12 closing price
Ad is loading...

AMEFX vs FASGX

Header iconAMEFX vs FASGX Comparison
Open Charts AMEFX vs FASGXBanner chart's image
American Funds Income Fund of Amer F2
Price$25.89
Change-$0.24 (-0.92%)
VolumeN/A
CapitalizationN/A
Fidelity Asset Manager 70%
Price$29.09
Change-$0.22 (-0.75%)
VolumeN/A
CapitalizationN/A
AMEFX vs FASGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMEFX vs. FASGX commentary
Nov 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMEFX is a Buy and FASGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
AMEFX has more cash in the bank: 129B vs. FASGX (6.74B). AMEFX pays higher dividends than FASGX: AMEFX (3.73) vs FASGX (1.63). AMEFX was incepted earlier than FASGX: AMEFX (16 years) vs FASGX (33 years). AMEFX is a more actively managed with annual turnover of: 40.00 vs. FASGX (19.00). FASGX has a lower initial minimum investment than AMEFX: FASGX (0) vs AMEFX (250). AMEFX (22.92) and FASGX (22.67) have marching annual gain over last year. FASGX return over 5 years is better than : 35.01 vs. AMEFX (24.77).
AMEFXFASGXAMEFX / FASGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years33 years-
Gain YTD13.13912.883102%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets129B6.74B1,915%
Annual Yield % from dividends3.731.63229%
Returns for 1 year22.9222.67101%
Returns for 3 years6.102.39256%
Returns for 5 years24.7735.0171%
Returns for 10 years38.7645.5285%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROL51.080.37
+0.72%
Rollins
OCC2.38N/A
+0.20%
Optical Cable Corp
AKYA3.19-0.03
-0.93%
Akoya BioSciences
CWAN29.79-1.23
-3.97%
Clearwater Analytics Holdings
PACB2.20-0.26
-10.57%
Pacific Biosciences of California